+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Brain & Spinal Cord Cancer Market by Tumor Type (Glioblastoma, Meningioma, Pituitary Tumors), Treatment (Diagnosis, Therapeutics), End-users - Forecast 2024-2030

  • PDF Icon

    Report

  • 193 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5968082
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Brain & Spinal Cord Cancer Market grew from USD 3.77 billion in 2023 to USD 3.98 billion in 2024. It is expected to continue growing at a CAGR of 5.75%, reaching USD 5.59 billion by 2030.

These cancers can disrupt the vital functions controlled by these areas, including muscle control, sensation, memory, and other cognitive abilities. Treatment plans for brain and spinal cord cancers are tailored to each individual's specific condition and may include surgery, radiation therapy, chemotherapy, targeted therapy, or a combination of these. This market's applications span across various medical fields, including neuro-oncology, neurosurgery, radiology, and palliative care. End-users are typically healthcare facilities such as hospitals, clinics, and specialized cancer treatment centers, besides patients requiring diagnostic, therapeutic, and supportive care services. Factors influencing the need for brain and spinal cord cancer treatment include advancements in medical technology, rising prevalence of brain and spinal cord cancers, increased investment in healthcare infrastructure, and awareness about these conditions. However, the market faces certain challenges, such as high treatment costs, limited accessibility to advanced healthcare facilities, and concerns associated with the complex nature of brain and spinal cord cancers. On the other hand, the incorporation of AI and machine learning in diagnostic processes and increasing preference for personalized medicine based on genetic profile present potential opportunities for the brain and spinal cord cancers market.

Regional Insights

In the Americas, particularly in the United States and Canada, significant investments in research and development have been made to advance the treatment of brain and spinal cord cancers. High healthcare expenses and the presence of major healthcare institutions and biotech firms have propelled advanced research initiatives, including precision medicine and novel therapeutics. In South America, Brazil and Argentina are witnessing moderate development in the treatment of the brain and spinal cord cancer market due to rising healthcare expenditure, increasing incidence of cancer, and gradual improvements in healthcare infrastructure. The EU countries boast a robust healthcare infrastructure and several ongoing initiatives for cancer research and early detection. Increased funding from both public and private sectors towards healthcare research has led to significant breakthroughs. Patients in this region benefit from universal healthcare systems, influencing their ability to access advanced treatments. The Middle East and Africa region encounters unique challenges, including variable healthcare infrastructure and accessibility issues. The focus is gradually shifting towards improving healthcare facilities and cancer care centers, with several governments and NGOs playing a pivotal role. The APAC region is witnessing a rapid transformation in the healthcare sector, driven by growing economies such as China, Japan, and India. These countries have seen a surge in healthcare spending and are at the forefront of technological innovation in cancer treatment. Consumer awareness and demand for quality cancer care are high, leading to greater government and private investment in healthcare infrastructure and research initiatives.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Brain & Spinal Cord Cancer Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Rising prevalence of brain and spinal cord cancers globally
  • Increased investment in healthcare infrastructure with growing awareness about these conditions
  • Ongoing government initiatives aimed at cancer research and early detection

Market Restraints

  • High treatment costs and limited accessibility to advanced healthcare facilities for brain and spinal cord cancer

Market Opportunities

  • Incorporation of AI and machine learning in diagnostic processes
  • Increasing preference for personalized medicine based on genetic profile

Market Challenges

  • Concerns associated with the complex nature of brain and spinal cord cancers

Market Segmentation Analysis

  • Treatment:
  • End-users:

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Brain & Spinal Cord Cancer Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Brain & Spinal Cord Cancer Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Diakonos’ brain tumor vaccine receives FDA’s orphan drug designation

The U.S. Food and Drug Administration (FDA) awarded Diakonos' dendritic cell vaccine, DOC1021, with orphan drug designation for its potential use in treating malignant glioma, specifically targeting newly diagnosed or refractory glioblastoma multiforme. This designation could pave the way for up to seven years of exclusive market rights following approval and tax benefits for domestic clinical trials.

Novartis Tafinlar + Mekinist approved by FDA for pediatric patients with BRAF V600E low-grade glioma, the most common pediatric brain cancer

Novartis AG received the U.S. Food and Drug Administration's approval of Tafinlar (dabrafenib) in combination with Mekinist (trametinib) for pediatric patients aged one year and above diagnosed with BRAF V600E mutation-positive low-grade glioma (LGG) requiring systemic therapy.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Brain & Spinal Cord Cancer Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Brain & Spinal Cord Cancer Market, highlighting leading vendors and their innovative profiles. These include Amgen Inc., Bayer AG, bluebird bio, Inc., Bristol Myers Squibb Company, Dr. Reddy’s Laboratories Ltd., Eisai Inc., F. Hoffmann-La Roche Ltd., Genentech, Inc., GlaxoSmithKline PLC, Illumina, Inc., Johnson & Johnson Services, Inc, Merck & Co., Inc., Nektar Therapeutics, Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals, Inc., Shimadzu Corporation, Siemens Healthineers, Teva Pharmaceutical Industries Ltd., and Y-mAbs Therapeutics A/S.

Market Segmentation & Coverage

This research report categorizes the Brain & Spinal Cord Cancer Market to forecast the revenues and analyze trends in each of the following sub-markets:

Tumor Type

  • Glioblastoma
  • Meningioma
  • Pituitary Tumors
  • Treatment

Diagnosis

  • Cerebral Arteriogram
  • CT Scan
  • EEG
  • Lumbar Puncture
  • Molecular Testing
  • MRI
  • PET-CT Scan
  • Tissue Sampling

Therapeutics

  • Chemotherapy
  • Immunotherapy
  • Radiation Therapy
  • Surgery
  • Targeted Therapy

End-users

  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Hospital & Clinics

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of brain and spinal cord cancers globally
5.1.1.2. Increased investment in healthcare infrastructure with growing awareness about these conditions
5.1.1.3. Ongoing government initiatives aimed at cancer research and early detection
5.1.2. Restraints
5.1.2.1. High treatment costs and limited accessibility to advanced healthcare facilities for brain and spinal cord cancer
5.1.3. Opportunities
5.1.3.1. Incorporation of AI and machine learning in diagnostic processes
5.1.3.2. Increasing preference for personalized medicine based on genetic profile
5.1.4. Challenges
5.1.4.1. Concerns associated with the complex nature of brain and spinal cord cancers
5.2. Market Segmentation Analysis
5.2.1. Treatment:
5.2.2. End-users:
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Brain & Spinal Cord Cancer Market, by Tumor Type
6.1. Introduction
6.2. Glioblastoma
6.3. Meningioma
6.4. Pituitary Tumors
7. Brain & Spinal Cord Cancer Market, by Treatment
7.1. Introduction
7.2. Diagnosis
7.3. Therapeutics
8. Brain & Spinal Cord Cancer Market, by End-users
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Diagnostic Centers
8.4. Hospital & Clinics
9. Americas Brain & Spinal Cord Cancer Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Brain & Spinal Cord Cancer Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Brain & Spinal Cord Cancer Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Diakonos’ brain tumor vaccine receives FDA’s orphan drug designation
12.3.2. Novartis Tafinlar + Mekinist approved by FDA for pediatric patients with BRAF V600E low-grade glioma, the most common pediatric brain cancer
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. BRAIN & SPINAL CORD CANCER MARKET RESEARCH PROCESS
FIGURE 2. BRAIN & SPINAL CORD CANCER MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BRAIN & SPINAL CORD CANCER MARKET DYNAMICS
FIGURE 7. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
FIGURE 10. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
FIGURE 12. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. BRAIN & SPINAL CORD CANCER MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. BRAIN & SPINAL CORD CANCER MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. BRAIN & SPINAL CORD CANCER MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY GLIOBLASTOMA, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY GLIOBLASTOMA, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY MENINGIOMA, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY MENINGIOMA, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY PITUITARY TUMORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY PITUITARY TUMORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CEREBRAL ARTERIOGRAM, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CEREBRAL ARTERIOGRAM, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CT SCAN, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CT SCAN, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY EEG, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY EEG, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY LUMBAR PUNCTURE, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY LUMBAR PUNCTURE, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY MOLECULAR TESTING, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY MOLECULAR TESTING, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY MRI, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY MRI, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY PET-CT SCAN, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY PET-CT SCAN, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TISSUE SAMPLING, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TISSUE SAMPLING, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY SURGERY, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY SURGERY, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 57. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 58. GLOBAL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 59. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
TABLE 60. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
TABLE 61. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 62. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 63. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 64. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 65. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 66. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 67. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 68. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 69. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 70. AMERICAS BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 71. ARGENTINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
TABLE 72. ARGENTINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
TABLE 73. ARGENTINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 74. ARGENTINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 75. ARGENTINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 76. ARGENTINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 77. ARGENTINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 78. ARGENTINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 79. ARGENTINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 80. ARGENTINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 81. BRAZIL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
TABLE 82. BRAZIL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
TABLE 83. BRAZIL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 84. BRAZIL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 85. BRAZIL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 86. BRAZIL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 87. BRAZIL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 88. BRAZIL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 89. BRAZIL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 90. BRAZIL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 91. CANADA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
TABLE 92. CANADA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
TABLE 93. CANADA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 94. CANADA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 95. CANADA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 96. CANADA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 97. CANADA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 98. CANADA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 99. CANADA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 100. CANADA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 101. MEXICO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
TABLE 102. MEXICO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
TABLE 103. MEXICO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 104. MEXICO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 105. MEXICO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 106. MEXICO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 107. MEXICO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 108. MEXICO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 109. MEXICO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 110. MEXICO BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 111. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
TABLE 112. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
TABLE 113. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 114. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 115. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 116. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 117. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 118. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 119. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 120. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 121. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 122. UNITED STATES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 123. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
TABLE 124. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
TABLE 125. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 126. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 127. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 128. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 129. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 130. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 131. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 132. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 133. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 134. ASIA-PACIFIC BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 135. AUSTRALIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
TABLE 136. AUSTRALIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
TABLE 137. AUSTRALIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 138. AUSTRALIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 139. AUSTRALIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 140. AUSTRALIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 141. AUSTRALIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 142. AUSTRALIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 143. AUSTRALIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 144. AUSTRALIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 145. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
TABLE 146. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
TABLE 147. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 148. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 149. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 150. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 151. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 152. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 153. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 154. CHINA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 155. INDIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
TABLE 156. INDIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
TABLE 157. INDIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 158. INDIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 159. INDIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 160. INDIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 161. INDIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 162. INDIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 163. INDIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 164. INDIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 165. INDONESIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
TABLE 166. INDONESIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
TABLE 167. INDONESIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 168. INDONESIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 169. INDONESIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 170. INDONESIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 171. INDONESIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 172. INDONESIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 173. INDONESIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 174. INDONESIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 175. JAPAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
TABLE 176. JAPAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
TABLE 177. JAPAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 178. JAPAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 179. JAPAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 180. JAPAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 181. JAPAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 182. JAPAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 183. JAPAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 184. JAPAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 185. MALAYSIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
TABLE 186. MALAYSIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
TABLE 187. MALAYSIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 188. MALAYSIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 189. MALAYSIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 190. MALAYSIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 191. MALAYSIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 192. MALAYSIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 193. MALAYSIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 194. MALAYSIA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 195. PHILIPPINES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
TABLE 196. PHILIPPINES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
TABLE 197. PHILIPPINES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 198. PHILIPPINES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 199. PHILIPPINES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 200. PHILIPPINES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 201. PHILIPPINES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 202. PHILIPPINES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 203. PHILIPPINES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 204. PHILIPPINES BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 205. SINGAPORE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
TABLE 206. SINGAPORE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
TABLE 207. SINGAPORE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 208. SINGAPORE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 209. SINGAPORE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 210. SINGAPORE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 211. SINGAPORE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 212. SINGAPORE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 213. SINGAPORE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 214. SINGAPORE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 215. SOUTH KOREA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
TABLE 216. SOUTH KOREA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
TABLE 217. SOUTH KOREA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 218. SOUTH KOREA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 219. SOUTH KOREA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 220. SOUTH KOREA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 221. SOUTH KOREA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 222. SOUTH KOREA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 223. SOUTH KOREA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 224. SOUTH KOREA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 225. TAIWAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
TABLE 226. TAIWAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
TABLE 227. TAIWAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 228. TAIWAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 229. TAIWAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 230. TAIWAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 231. TAIWAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 232. TAIWAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 233. TAIWAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 234. TAIWAN BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 235. THAILAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
TABLE 236. THAILAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
TABLE 237. THAILAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 238. THAILAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 239. THAILAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 240. THAILAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 241. THAILAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 242. THAILAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 243. THAILAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 244. THAILAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 245. VIETNAM BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
TABLE 246. VIETNAM BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
TABLE 247. VIETNAM BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 248. VIETNAM BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 249. VIETNAM BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 250. VIETNAM BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 251. VIETNAM BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 252. VIETNAM BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 253. VIETNAM BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 254. VIETNAM BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA BRAIN & SPINAL CORD CANCER MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 267. DENMARK BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
TABLE 268. DENMARK BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
TABLE 269. DENMARK BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 270. DENMARK BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 271. DENMARK BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 272. DENMARK BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 273. DENMARK BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 274. DENMARK BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 275. DENMARK BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 276. DENMARK BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 277. EGYPT BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
TABLE 278. EGYPT BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
TABLE 279. EGYPT BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 280. EGYPT BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 281. EGYPT BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 282. EGYPT BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 283. EGYPT BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 284. EGYPT BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 285. EGYPT BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 286. EGYPT BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 287. FINLAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
TABLE 288. FINLAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
TABLE 289. FINLAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 290. FINLAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 291. FINLAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 292. FINLAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 293. FINLAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 294. FINLAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 295. FINLAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 296. FINLAND BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 297. FRANCE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
TABLE 298. FRANCE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
TABLE 299. FRANCE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 300. FRANCE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 301. FRANCE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 302. FRANCE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 303. FRANCE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 304. FRANCE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 305. FRANCE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 306. FRANCE BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 307. GERMANY BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
TABLE 308. GERMANY BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
TABLE 309. GERMANY BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 310. GERMANY BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 311. GERMANY BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 312. GERMANY BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 313. GERMANY BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 314. GERMANY BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 315. GERMANY BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 316. GERMANY BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 317. ISRAEL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
TABLE 318. ISRAEL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2024-2030 (USD MILLION)
TABLE 319. ISRAEL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 320. ISRAEL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 321. ISRAEL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2018-2023 (USD MILLION)
TABLE 322. ISRAEL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY DIAGNOSIS, 2024-2030 (USD MILLION)
TABLE 323. ISRAEL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2018-2023 (USD MILLION)
TABLE 324. ISRAEL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY THERAPEUTICS, 2024-2030 (USD MILLION)
TABLE 325. ISRAEL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 326. ISRAEL BRAIN & SPINAL CORD CANCER MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 327. ITALY BRAIN & SPINAL CORD CANCER MARKET SIZE, BY TUMOR TYPE, 2018-2023 (USD MILLION)
TABLE 328. ITALY BRAIN & SPINAL CORD CANC

Companies Mentioned

  • Amgen Inc.
  • Bayer AG
  • bluebird bio, Inc.
  • Bristol Myers Squibb Company
  • Dr. Reddy’s Laboratories Ltd.
  • Eisai Inc.
  • F. Hoffmann-La Roche Ltd.
  • Genentech, Inc.
  • GlaxoSmithKline PLC
  • Illumina, Inc.
  • Johnson & Johnson Services, Inc
  • Merck & Co., Inc.
  • Nektar Therapeutics
  • Novartis AG
  • Pfizer Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Shimadzu Corporation
  • Siemens Healthineers
  • Teva Pharmaceutical Industries Ltd.
  • Y-mAbs Therapeutics A/S

Methodology

Loading
LOADING...

Table Information